Tatjana Honstein
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry.
Journal: Acta dermato-venereologica
Published: April 16, 2026
Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.
Journal: Acta dermato-venereologica
Published: March 26, 2026
Patient treatment needs in atopic dermatitis: A real-world cohort study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 15, 2026
Staphylococcus aureus serine protease-like protein B elicits a type 1/type 2 immune response in atopic dermatitis patients.
Journal: Frontiers in immunology
Published: January 28, 2026
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany.
Journal: Skin health and disease
Published: November 28, 2025
The show must go on: an update on clinical experiences and clinical studies on novel pharmaceutical developments for the treatment of atopic dermatitis.
Journal: Current opinion in allergy and clinical immunology
Published: May 27, 2020
Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.
Journal: British journal of cancer
Published: March 27, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026